Australia markets closed

Cocrystal Pharma, Inc. (COCP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5550+0.0350 (+2.30%)
At close: 04:00PM EDT
1.4850 -0.07 (-4.50%)
After hours: 07:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 15.82M
Enterprise value -8.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.60
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.41

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-35.54%
S&P500 52-week change 322.36%
52-week high 33.2900
52-week low 31.3300
50-day moving average 31.4946
200-day moving average 31.8923

Share statistics

Avg vol (3-month) 313.69k
Avg vol (10-day) 310.81k
Shares outstanding 510.17M
Implied shares outstanding 610.17M
Float 87.11M
% held by insiders 130.03%
% held by institutions 16.72%
Shares short (15 Apr 2024) 41.49k
Short ratio (15 Apr 2024) 40.08
Short % of float (15 Apr 2024) 40.02%
Short % of shares outstanding (15 Apr 2024) 40.01%
Shares short (prior month 15 Mar 2024) 43.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 Jan 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 311 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.68%
Return on equity (ttm)-54.54%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.97M
Net income avi to common (ttm)-17.98M
Diluted EPS (ttm)-1.8700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.35M
Total cash per share (mrq)2.59
Total debt (mrq)1.85M
Total debt/equity (mrq)7.02%
Current ratio (mrq)8.92
Book value per share (mrq)2.59

Cash flow statement

Operating cash flow (ttm)-14.67M
Levered free cash flow (ttm)-10.01M